Molecular Partners to Participate in Upcoming Healthcare Investor Conferences

Rhea-AI Summary

Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech firm specializing in DARPin therapeutics, will participate in two investor events in May. The company is set to publish its Q1 2022 earnings report on May 12, 2022, after NASDAQ trading hours. Key events include the RBC Capital Markets Global Healthcare Conference from May 17-18, featuring a fireside chat on May 17 at 9:00 am ET, and BioEquity Europe 2022 with virtual meetings on May 23-24. Presentations will be available online.

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., May 11, 2022 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, today announced that members of its management team will participate in two upcoming investor events. In addition, the Company will publish its Q1 2022 earnings report on May 12, after the close of trading at the NASDAQ exchange.

Conference Details:

• 2022 RBC Capital Markets Global Healthcare Conference, in-person, May 17-18, 2022
  
  
  • Fireside chat – Tuesday, May 17, 2022, at 9:00am ET
    
    
• BioEquity Europe 2022 – virtual 1x1 meetings, Monday-Tuesday, May 23-24, 2022

• Virtual presentation made available on-demand
  

Presentations will be made available through the Molecular Partners website.

About Molecular Partners AG 
Molecular Partners AG is a clinical-stage biotech company developing DARPin therapeutics, a new class of custom-built protein drugs designed to address challenges current modalities cannot. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics in the areas of ophthalmology, oncology and infectious disease, and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas. www.molecularpartners.com; Find us on Twitter - @MolecularPrtnrs

FAQ

When will Molecular Partners AG announce its Q1 2022 earnings report?

Molecular Partners AG will publish its Q1 2022 earnings report on May 12, 2022, after NASDAQ trading hours.

What events will Molecular Partners AG participate in May 2022?

Molecular Partners AG will participate in the RBC Capital Markets Global Healthcare Conference on May 17-18 and BioEquity Europe 2022 on May 23-24, 2022.

What is the format of the RBC Capital Markets Global Healthcare Conference for Molecular Partners AG?

The RBC Capital Markets Global Healthcare Conference will include an in-person participation by Molecular Partners AG with a fireside chat on May 17, 2022.

How can I access the presentations by Molecular Partners AG during the upcoming events?

Presentations by Molecular Partners AG will be available on-demand through their official website.